• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

设计用于增加内部过滤的透析器不会导致血小板活化和凝血酶生成显著增加。

Dialyzers designed to increase internal filtration do not result in significantly increased platelet activation and thrombin generation.

机构信息

Centre for Nephrology, Royal Free Hospital, London, UK.

出版信息

Nephron Clin Pract. 2011;117(4):c403-8. doi: 10.1159/000319884. Epub 2010 Nov 12.

DOI:10.1159/000319884
PMID:21071966
Abstract

INTRODUCTION

To increase middle molecule clearances, high-flux dialyzers with increased internal filtration have been developed. However, dialyzer design and structure may affect thrombin generation and platelet activation, thereby risking increased clotting and reduced dialyzer clearances.

METHODS

Coagulation parameters, platelet, white cell and endothelial activation markers were measured prior to and following dialysis sessions in 12 patients using two different dialyzers designed for increased internal filtration.

RESULTS

Prior to dialysis, patients had evidence of activation of coagulation with increased factor VIII:C, thrombin-antithrombin complexes and prothrombin fragment 1+2, increased platelet activation, with raised platelet factor 4, β-thromboglobulin levels and increased fibrinolysis (raised D-dimers). Dialysis was associated with the release of soluble platelet integrin, sP selectin, increased endothelial activation with increased levels of von Willebrand factor (vWF) antigen (vWF:Ag) and vWF propeptide (vWF:pp) and sE selectin. There was no difference in tinzaparin levels at the end of the dialysis session using either dialyzer, as shown by anti-Xa activity - 0.145 ± 0.027 versus 0.11 ± 0.017 IU/ml, respectively.

CONCLUSION

Haemodialysis patients have an inflammatory phenoytype, characterized by increased activation of coagulation, platelets and also fibrinolysis. However, dialyzers designed to increase internal filtration did not significantly increase platelet activation or thrombin generation.

摘要

简介

为了提高中分子清除率,开发了具有更高内滤过的高通量透析器。然而,透析器的设计和结构可能会影响凝血酶生成和血小板活化,从而增加凝血风险并降低透析器的清除率。

方法

在 12 名患者中,使用两种不同的、设计用于增加内滤过的透析器,在透析前后测量凝血参数、血小板、白细胞和内皮细胞激活标志物。

结果

在透析前,患者存在凝血激活的证据,表现为因子 VIII:C、凝血酶-抗凝血酶复合物和凝血酶原片段 1+2 增加,血小板活化增加,血小板因子 4、β-血栓球蛋白水平升高,纤维蛋白溶解增加(D-二聚体升高)。透析与可溶性血小板整合素的释放、血小板选择素 sP 升高、血管性血友病因子 (vWF) 抗原 (vWF:Ag) 和 vWF 前肽 (vWF:pp) 增加以及 sE 选择素增加有关。两种透析器在透析结束时的亭扎肝素水平没有差异,抗 Xa 活性分别为 0.145±0.027IU/ml 和 0.11±0.017IU/ml。

结论

血液透析患者存在炎症表型,其特征为凝血、血小板和纤溶活性增加。然而,设计用于增加内滤过的透析器并没有显著增加血小板活化或凝血酶生成。

相似文献

1
Dialyzers designed to increase internal filtration do not result in significantly increased platelet activation and thrombin generation.设计用于增加内部过滤的透析器不会导致血小板活化和凝血酶生成显著增加。
Nephron Clin Pract. 2011;117(4):c403-8. doi: 10.1159/000319884. Epub 2010 Nov 12.
2
Increased thrombin generation and platelet activation are associated with deficiency in high molecular weight multimers of von Willebrand factor in patients with moderate-to-severe aortic stenosis.在中重度主动脉瓣狭窄患者中,凝血酶生成增加和血小板活化与 von Willebrand 因子高分子量多聚体缺乏有关。
Heart. 2011 Dec;97(24):2023-8. doi: 10.1136/hrt.2010.217273. Epub 2011 May 10.
3
Platelet activation and clotting cascade activation by dialyzers designed for high volume online hemodiafiltration.用于高容量在线血液透析滤过的透析器引起的血小板活化和凝血级联反应活化。
Hemodial Int. 2018 Apr;22(2):192-200. doi: 10.1111/hdi.12586. Epub 2017 Aug 1.
4
Does an alteration of dialyzer design and geometry affect biocompatibility parameters?透析器设计和几何形状的改变会影响生物相容性参数吗?
Hemodial Int. 2006 Apr;10(2):201-8. doi: 10.1111/j.1542-4758.2006.00095.x.
5
Obstructive hypertrophic cardiomyopathy is associated with enhanced thrombin generation and platelet activation.梗阻性肥厚型心肌病与凝血酶生成增加和血小板活化有关。
Heart. 2008 Jun;94(6):e21. doi: 10.1136/hrt.2007.126896. Epub 2007 Oct 8.
6
Platelet heterogeneity: variation in coagulation complexes on platelet subpopulations.血小板异质性:血小板亚群上凝血复合物的变化。
Arterioscler Thromb Vasc Biol. 2005 Apr;25(4):861-6. doi: 10.1161/01.ATV.0000155987.26583.9b. Epub 2005 Jan 13.
7
Activation of coagulation and fibrinolysis in childhood diarrhoea-associated haemolytic uraemic syndrome.儿童腹泻相关性溶血尿毒综合征中凝血和纤溶的激活
Thromb Haemost. 1997 Dec;78(6):1450-5.
8
The influence of dialyzer geometry on blood coagulation and biocompatibility.透析器几何形状对血液凝固和生物相容性的影响。
Clin Nephrol. 1993 Nov;40(5):281-5.
9
A prospective study of G-CSF effects on hemostasis in allogeneic blood stem cell donors.一项关于粒细胞集落刺激因子(G-CSF)对异基因造血干细胞供者止血作用的前瞻性研究。
Bone Marrow Transplant. 1999 May;23(10):991-6. doi: 10.1038/sj.bmt.1701756.
10
The influence of the haemodialysis procedure on platelets, coagulation and fibrinolysis.血液透析程序对血小板、凝血和纤溶的影响。
Pathophysiol Haemost Thromb. 2005;34(6):274-8. doi: 10.1159/000093107.

引用本文的文献

1
The effect of SARS-Co-V2 infection on prothrombotic and anticoagulant factors in dialysis patients.SARS-CoV-2 感染对透析患者促血栓形成和抗凝因子的影响。
Artif Organs. 2022 Jul;46(7):1328-1333. doi: 10.1111/aor.14206. Epub 2022 Mar 14.
2
Changes in extracellular water with hemodialysis and fall in systolic blood pressure.血液透析时细胞外液的变化与收缩压下降。
Int J Artif Organs. 2022 Feb;45(2):140-145. doi: 10.1177/0391398821995503. Epub 2021 Feb 20.
3
CD62P and P10 as predictive markers for assessing the efficacy of hemodialysis in treating end-stage renal disease.
CD62P和P10作为评估血液透析治疗终末期肾病疗效的预测标志物。
J Clin Lab Anal. 2019 Feb;33(2):e22662. doi: 10.1002/jcla.22662. Epub 2018 Oct 15.
4
Changes in body composition following haemodialysis as assessed by bioimpedance spectroscopy.通过生物电阻抗光谱法评估血液透析后身体成分的变化。
Eur J Clin Nutr. 2017 Feb;71(2):169-172. doi: 10.1038/ejcn.2016.187. Epub 2016 Sep 28.
5
Where and When To Inject Low Molecular Weight Heparin in Hemodiafiltration? A Cross Over Randomised Trial.血液滤过中低分子量肝素应在何时何地注射?一项交叉随机试验。
PLoS One. 2015 Jun 15;10(6):e0128634. doi: 10.1371/journal.pone.0128634. eCollection 2015.
6
Changes in muscle and fat mass with haemodialysis detected by multi-frequency bioelectrical impedance analysis.通过多频生物电阻抗分析检测血液透析过程中肌肉和脂肪量的变化。
Eur J Clin Nutr. 2015 Oct;69(10):1109-12. doi: 10.1038/ejcn.2015.90. Epub 2015 Jun 3.
7
Portable and wearable dialysis devices for the treatment of patients with end-stage kidney failure: Wishful thinking or just over the horizon?用于治疗终末期肾衰竭患者的便携式和可穿戴透析设备:是痴心妄想还是即将成为现实?
Pediatr Nephrol. 2015 Dec;30(12):2053-60. doi: 10.1007/s00467-014-2968-3. Epub 2014 Oct 21.
8
Aortic pulse wave velocity in haemodialysis patients is associated with the prescription of active vitamin D analogues.血液透析患者的主动脉脉搏波速度与活性维生素D类似物的处方有关。
J Nephrol. 2014 Aug;27(4):431-7. doi: 10.1007/s40620-014-0040-9. Epub 2014 Jan 29.
9
Do higher dialysate calcium concentrations increase vascular stiffness in haemodialysis patients as measured by aortic pulse wave velocity?通过主动脉脉搏波速度测量,更高的透析液钙浓度会增加血液透析患者的血管僵硬度吗?
BMC Nephrol. 2013 Sep 8;14:189. doi: 10.1186/1471-2369-14-189.
10
Alternatives to standard unfractionated heparin for pediatric hemodialysis treatments.儿科血液透析治疗中标准未分级肝素的替代选择。
Pediatr Nephrol. 2012 Oct;27(10):1869-79. doi: 10.1007/s00467-012-2129-5. Epub 2012 Feb 29.